Cleared Traditional

K792525 - IREX CARDIOPLAN

K792525 is an FDA 510(k) clearance for IREX CARDIOPLAN, manufactured by Irex Corp.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K792525 · Irex Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1979
Decision
21d
Days
Class 2
Risk

K792525 is an FDA 510(k) clearance for the IREX CARDIOPLAN. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Irex Corp. (Mchenry, US). The FDA issued a Cleared decision on December 27, 1979 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Irex Corp. devices

FDA 510(k) Submission Details - K792525

510(k) Number K792525 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 1979
Decision Date December 27, 1979
Days to Decision 21 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 125d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 376
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K792525.
PDS CARDIAC CALC. SOFTW. PROGR. #A3604AE
K810750 · General Electric Co. · Mar 1981
PACEMAKER PATIENT MGMT. SYSTEM
K801810 · Siemens Elema AB · Feb 1981
DATABASE MANAGEMENT & REPORTING SYSTEM
K792677 · Honeywell, Inc. · Jan 1980
ARRHYTHMIA II EDITOR
K791776 · Spacelabs, Inc. · Oct 1979
QUINTON STATUS 1000
K782072 · Quinton, Inc. · Feb 1979
MODEL 5621A INTERFACE
K780768 · Hewlett-Packard Co. · May 1978